Skip to content

Postoperative Renal Failure in Cardiac Surgery PMSF-PVC Gradient Study

Postoperative Renal Failure in Cardiac Surgery PMSF-PVC Gradient Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04062786
Acronym
PMSF-PVC
Enrollment
130
Registered
2019-08-20
Start date
2019-02-21
Completion date
2020-02-29
Last updated
2019-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Bypass, Scheduled Heart Surgery, Valve Replacement

Brief summary

Acute renal failure is a frequent and severe postoperative complication of cardiac surgery performed under extracorporeal circulation. It is an independent risk factor for mortality and significantly increases the length of hospital stay. The origin of renal insufficiency after extracorporeal circulation is multifactorial (long duration of extracorporeal circulation, hemodynamic instability per and post-extracorporeal circulation, prolonged hypotension, transfusion ...). Nevertheless, an entirely different pathophysiological mechanism, though not recent, is less often mentioned but shows renewed interest. This is the concept of renal venous congestion which may be responsible for impaired renal function in the absence of cardiac dysfunction. Based on Guyton's circulatory model, the investigators approach this systemic venous hypertension through the measurement of the Pmsf-PVC gradient.

Interventions

OTHERPmsf-PVC gradient measurement

implementation of standard standard hemodynamic monitorin

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* age\> 18 years * subject having signed an informed consent * scheduled heart surgery: * Valve replacement * Coronary artery bypass

Exclusion criteria

* Any urgent surgery or redux * Severe preoperative chronic renal failure (stage III) defined by GFR \<30ml / min * Existence of rhythm disorders (permanent ACFA) or serious cardiac conduction disorders, patients with Pacemaker * Preoperative alteration of left ventricular ejection fraction with LVEF \<40% * Major haemodynamic instability with refractory shock defined by dobutamine ≥10μg / kg / min and / or norepinephrine ≥ 1μg / kg / min and / or epinephrine ≥ 0.2μg / kg / min. * Intra-aortic versus assisted pelvic balloon * Contraindication to femoral arterial catheterization * Subject under the protection of justice, subject under guardianship or under tutorship * Impossibility of giving the subject informed information (subject in emergency situation, difficulties in understanding the subject)

Design outcomes

Primary

MeasureTime frameDescription
Evolution of the gradient Pmsf (arm) -PVC24 hoursMonitor the evolution of the Pmsf (arm) -PVC gradient at H24 and compare this gradient between the two patient populations (with and without postoperative acute renal failure)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026